Pharma

Your Article Summary

See Latest Articles

Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S. -- Bayer subsidiary Intendis expands presence in the U.S. / Asset purchase agreement signed for marketed prescription products Desonate and NeoBenz Micro
BayNews International, 09/03/09

Intendis GmbH, which is part of Bayer HealthCare, announced that it has signed an agreement to acquire two prescription dermatology product lines from SkinMedica, Inc., a dermatology company based in Carlsbad, CA, USA. Both Desonate and NeoBenz Micro are currently marketed in the U.S. by SkinMedica, Inc. Under the transaction, which is still subject to the necessary regulatory approvals, Intendis will acquire all commercial rights, including assigned contracts and intellectual property related to the two product lines.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Go Go Generics
PharmExec, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09

 See all of Marketing/Media/ROI